Protein kinase D1mRNA level may predict cancer-specific survival in heavy smokers with esophageal squamous cell cancers

Diseases of the Esophagus

Volumn 27, Issue 2, 2014, Pages 188-195

  Xie, X ^a   Zhang, S S ^a   Wen, J ^a   Yang, H ^a   Luo, K J ^a   Yang, F ^a   Hu, Y ^a   Fu, J H ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Esophageal cancer; Outcome; Protein kinase D1; Smoking; Tumor marker

Indexed keywords

MESSENGER RNA; PROTEIN KINASE D; PROTEIN KINASE C; PROTEIN KINASE D1; TUMOR MARKER;

ADULT; APOPTOSIS; ARTICLE; CANCER CENTER; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CARCINOGENESIS; CELL ADHESION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDEPENDENT VARIABLE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SMOKING; AGED; DISEASE FREE SURVIVAL; ESOPHAGUS CANCER; ESOPHAGUS TUMOR; GENETICS; METABOLISM; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UPREGULATION;

ESOPHAGEAL CANCER; OUTCOME; PROTEIN KINASE D1; SMOKING; TUMOR MARKER;

AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN KINASE C; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; SMOKING; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84893008966     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12077     Document Type: Article

References (35)

1. Ferlay J, Shin H R, Bray F, Forman D, Mathers C, Parkin D M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Sjoquist K M, Burmeister B H, Smithers B M etal. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 2011; 12: 681-692.
3. Kawaguchi T, Matsumura A, Fukai S etal. Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases. J Thorac Oncol 2010; 5: 1001-1010.
4. Dikshit R P, Boffetta P, Bouchardy C etal. Lifestyle habits as prognostic factors in survival of laryngeal and hypopharyngeal cancer: a multicentric European study. Int J Cancer 2005; 117: 992-995.
5. Thrift A P, Nagle C M, Fahey P P etal. The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival. Int J Cancer 2012; 131: E759-768.
6. Pelucchi C G S, Garavello W, Bosetti C, La Vecchia C. Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev 2008; 17: 340-344.
7. Tramacere I, La Vecchia C, Negri E. Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis. Epidemiology 2011; 22: 344-349.
8. Cook M B, Kamangar F, Whiteman D C etal. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst 2010; 102: 1344-1353.
9. Sun X, Chen W, Chen Z, Wen D, Zhao D, He Y. Population-based case-control study on risk factors for esophageal cancer in five high-risk areas in China. Asian Pac J Cancer Prev 2010; 11: 1631-1636.
10. Shitara K, Matsuo K, Hatooka S etal. Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective study. Cancer Sci 2010; 101: 1001-1006.
11. Sundelof M, Lagergren J, Ye W. Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Eur J Cancer 2008; 44: 1566-1571.
12. Lin Y, Su X, Su H etal. Prediagnostic smoking and postoperative survival in lymph node-negative esophagus squamous cell carcinoma patients. Cancer Sci 2012; 103: 1985-1988.
13. Sundram V, Chauhan S C, Jaggi M. Emerging roles of protein kinase D1 in cancer. Mol Cancer Res 2011; 9: 985-996.
14. Van Lint J, Rykx A, Maeda Y etal. Protein kinase D: an intracellular traffic regulator on the move. Trends Cell Biol 2002; 12: 193-200.
15. Rozengurt E, Rey O, Waldron R T. Protein kinase D signaling. J Biol Chem 2005; 280: 13205-13208.
16. Eiseler T, Doppler H, Yan I K, Goodison S, Storz P. Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Res 2009; 11: R13.
17. Jaggi M, Rao P S, Smith D J, Hemstreet G P, Balaji K C. Protein kinase C mu is down-regulated in androgen-independent prostate cancer. Biochem Biophys Res Commun 2003; 307: 254-260.
18. Shabelnik M Y, Kovalevska L M, Yurchenko M Y, Shlapatska L M, Rzepetsky Y, Sidorenko S P. Differential expression of PKD1 and PKD2 in gastric cancer and analysis of PKD1 and PKD2 function in the model system. Exp Oncol 2011; 33: 206-211.
19. Ochi N, Tanasanvimon S, Matsuo Y etal. Protein kinase D1 promotes anchorage-independent growth, invasion, and angiogenesis by human pancreatic cancer cells. J Cell Physiol 2011; 226: 1074-1081.
20. Ristich V L, Bowman P H, Dodd M E, Bollag W B. Protein kinase D distribution in normal human epidermis, basal cell carcinoma and psoriasis. Br J Dermatol 2006; 154: 586-593.
21. Rice T W, Rusch V W, Ishwaran H, Blackstone E H. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer 2010; 116: 3763-3773.
22. Guha S, Rey O, Rozengurt E. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. Cancer Res 2002; 62: 1632-1640.
23. Wagner E F, Nebreda A R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009; 9: 537-549.
24. Storz P. Mitochondrial ROS - radical detoxification, mediated by protein kinase D. Trends Cell Biol 2007; 17: 13-18.
25. Trauzold A, Schmiedel S, Sipos B etal. PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells. Oncogene 2003; 22: 8939-8947.
26. Kim M, Jang H R, Kim J H etal. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion. Carcinogenesis 2008; 29: 629-637.
27. Lavalle C R, Bravo-Altamirano K, Giridhar K V etal. Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility. BMC Chem Biol 2010; 10: 5.
28. Bowden E T, Barth M, Thomas D, Glazer R I, Mueller S C. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 1999; 18: 4440-4449.
29. Pryor W A, Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993; 686: 12-27.
30. Cross C E, O'Neill C A, Reznick A Z etal. Cigarette smoke oxidation of human plasma constituents. Ann N Y Acad Sci 1993; 686: 72-89.
31. Jaggi M, Du C, Zhang W, Balaji K C. Protein kinase D1: a protein of emerging translational interest. Front Biosci 2007; 12: 3757-3767.
32. Morita M, Kumashiro R, Kubo N etal. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol 2010; 15: 126-134.
33. Kamangar F, Strickland P T, Pourshams A etal. High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res 2005; 25: 425-428.
34. Zhou Q Z, Liu H B, Ding X C, Li P, Zhang S T, Yu Z L. Aspirin inhibits the proliferation of tobacco-related esophageal squamous carcinomas cell lines through cyclooxygenase 2 pathway. Chin Med J (Engl) 2007; 120: 2086-2091.
35. Rodriguez Perez C E, Nie W, Sinnett-Smith J, Rozengurt E, Yoo J. TNF-alpha potentiates lysophosphatidic acid-induced COX-2 expression via PKD in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol 2011; 300: G637-646.